Cardiac Biomarkers Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Cardiac Biomarkers Market By Biomarker Type (Natriuretic Peptides (BNP And NT-ProBNP), Ischemia Modified Albumin, Creatine Kinase, Myoglobin, Troponins (T,I), and Others), By Disease Type (Acute Coronary Syndrome, Congestive Heart Failure, Atherosclerosis, Myocardial Infarction, and Others), By End User (Laboratory Testing, Point of Care Testing), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global cardiac biomarkers market size valued USD  13.08 billion in 2020 and expected to reach USD 25.08 billion by 2027, at a CAGR of 10.08% during the forecast period 2021-2027. Cardiac biomarkers are the substances that usually released into the blood when the heart is stressed or damaged. They are helpful in the diagnosis of an acute coronary syndrome (ACS) and cardiac ischemia, and other conditions associated with insufficient blood flow to the heart. The test for cardiac biomarkers is used to determine an individual’s risk of having the above conditions.

Cardiac Biomarkers Market

MARKET SUMMARY
-
10.08% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 10.08%
  • Largest Market– North-America
  • Fastest Growing Market– Asia-Pacific

Cardiac Biomarkers Market

  • The report on global cardiac biomarkers market gives historical, current and future market sizes (US$ Bn) based on biomarker type, application, disease type, end user and region.
  • cardiac biomarkers market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Randox laboratories
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthcare
  • Alere Inc.
Cardiac Biomarkers Market

Drivers And Restraints

Increase in the prevalence of cardiovascular diseases anticipated to drive the growth of the cardiac biomarkers market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) take the lives of 17.7 million people every year, 31% of all global deaths. Growing awareness among the people regarding the early diagnosis of the disease is expected to fuel the market. The factors such as highly accurate results and point of care testing are driving the growth of the market. However, the poor reimbursement policies are likely to hamper the growth of the market. The stringent government regulations for test approvals are hindering the growth of the cardiac biomarkers market.


North-America got significant share

Cardiac Biomarkers Market

Geographically, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America market is the dominant market when compared with that of other regional markets owing to its deep-rooted healthcare infrastructure. The adoption of the modern diagnosis and treatment methods for cardiac disease is adding fuel for the growth of the market. Europe cardiac biomarkers market falls next to that of North America region in the global cardiac biomarkers market. The Asia Pacific cardiac biomarkers market is expected to grow over the forecast period owing to increase in the prevalence of the cardiac diseases. The developing healthcare infrastructure is adding fuel for the growth of the cardiac biomarkers market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In January 2017, Roche has received 510(k) clearance for its Elecsys Troponin T Gen 5 STAT (TnT Gen 5 STAT) blood test for patients with a suspected heart attack.

Key

Key Features of the Report

Cardiac Biomarkers Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

  1. Table of Content
  2. Executive Summary
  3. Global Cardiac Biomarkers Market Introduction
    • Global Cardiac Biomarkers Market – Taxonomy
    • Global Cardiac Biomarkers Market –Definitions
      • Biomarker Type
      • Disease Type
  1. Global Cardiac Biomarkers Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Cardiac Biomarkers Market Dynamic Factors – Impact Analysis
    • Global Cardiac Biomarkers Market – Competition Landscape
    • Epidemiology
  2. Global Cardiac Biomarkers Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Cardiac Biomarkers Market, By Biomarker Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Natriuretic Peptides (BNP And NT-ProBNP)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ischemia Modified Albumin
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Creatine Kinase
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Myoglobin
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Troponins (T,I)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cardiac Biomarkers Market Forecast, By Disease Type, 2013 – 2017 and Forecast, 2018 – 2024
    • Acute Coronary Syndrome
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Congestive Heart Failure
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Atherosclerosis
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Myocardial Infarction
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cardiac Biomarkers Market Forecast, By End User, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Laboratory Testing
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Point of Care Testing
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cardiac Biomarkers Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Cardiac Biomarkers Market – Opportunity Analysis Index, By Biomarker Type, By Disease Type, By End User,and Region, 2018 – 2024
  2. North America Cardiac Biomarkers MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Biomarker Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Natriuretic Peptides (BNP And NT-ProBNP)
      • Ischemia Modified Albumin
      • Creatine Kinase
      • Myoglobin
      • Troponins (T,I)
      • Others
    • Disease Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Acute Coronary Syndrome
      • Congestive Heart Failure
      • Atherosclerosis
      • Myocardial Infarction
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laboratory Testing
      • Point of Care Testing
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Cardiac Biomarkers Market – Opportunity Analysis Index, By Biomarker Type, By Disease Type, By End User, and Country, 2018 – 2024
    • North America Cardiac Biomarkers Market Dynamics – Trends
  3. Europe Cardiac Biomarkers Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Biomarker Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Natriuretic Peptides (BNP And NT-ProBNP)
      • Ischemia Modified Albumin
      • Creatine Kinase
      • Myoglobin
      • Troponins (T,I)
      • Others
    • Disease Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Acute Coronary Syndrome
      • Congestive Heart Failure
      • Atherosclerosis
      • Myocardial Infarction
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laboratory Testing
      • Point of Care Testing
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Cardiac Biomarkers Market – Opportunity Analysis Index, By Biomarker Type, By Disease Type, By End User, and Country, 2018 – 2024
    • Europe Cardiac Biomarkers Market Dynamics – Trends
  4. Asia-Pacific Cardiac Biomarkers Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Biomarker Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Natriuretic Peptides (BNP And NT-ProBNP)
      • Ischemia Modified Albumin
      • Creatine Kinase
      • Myoglobin
      • Troponins (T,I)
      • Others
    • Disease Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Acute Coronary Syndrome
      • Congestive Heart Failure
      • Atherosclerosis
      • Myocardial Infarction
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laboratory Testing
      • Point of Care Testing
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Cardiac Biomarkers Market – Opportunity Analysis Index, By Biomarker Type, By Disease Type, By End User, and Country, 2018 – 2024
    • Asia-Pacific Cardiac Biomarkers Market Dynamics – Trends
  5. Latin America Cardiac Biomarkers Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Biomarker Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Natriuretic Peptides (BNP And NT-ProBNP)
      • Ischemia Modified Albumin
      • Creatine Kinase
      • Myoglobin
      • Troponins (T,I)
      • Others
    • Disease Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Acute Coronary Syndrome
      • Congestive Heart Failure
      • Atherosclerosis
      • Myocardial Infarction
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laboratory Testing
      • Point of Care Testing
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Cardiac Biomarkers Market – Opportunity Analysis Index, By Biomarker Type, By Disease Type, By End User, and Country, 2018 – 2024
    • Latin America Cardiac Biomarkers Market Dynamics – Trends
  6. Middle East and Africa Cardiac Biomarkers Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Biomarker Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Natriuretic Peptides (BNP And NT-ProBNP)
      • Ischemia Modified Albumin
      • Creatine Kinase
      • Myoglobin
      • Troponins (T,I)
      • Others
    • Disease Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Acute Coronary Syndrome
      • Congestive Heart Failure
      • Atherosclerosis
      • Myocardial Infarction
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Laboratory Testing
      • Point of Care Testing
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Cardiac Biomarkers Market – Opportunity Analysis Index, By Biomarker Type, By Disease Type, By End User, and Country, 2018 – 2024
    • MEA Cardiac Biomarkers Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Biomaker Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Randox laboratories (UK)
      • Thermo Fisher Scientific (U.S)
      • Roche Diagnostics (Switzerland)
      • Abbott Laboratories (U.S)
      • Siemens Healthcare (Germany)
      • Alere Inc. (U.S)
      • Becton, Dickinson and Company (U.S)
      • Bio-Rad Laboratories (U.S)
      • BioMerieux (France)
      • Beckman Coulter (U.S)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

  1. Disclaimer
  2. The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

Report

Company Profile

  • Randox laboratories (UK)
  • Thermo Fisher Scientific (U.S)
  • Roche Diagnostics (Switzerland)
  • Abbott Laboratories (U.S)
  • Siemens Healthcare (Germany)
  • Alere Inc. (U.S)
  • Becton, Dickinson and Company (U.S)
  • Bio-Rad Laboratories (U.S)
  • BioMerieux (France)
  • Beckman Coulter (U.S)

Description

The global cardiac biomarkers market size valued USD  13.08 billion in 2020 and expected to reach USD 25.08 billion by 2027, at a CAGR of 10.08% during the forecast period 2021-2027. Cardiac biomarkers are the substances that usually released into the blood when the heart is stressed or damaged. They are helpful in the diagnosis of an acute coronary syndrome (ACS) and cardiac ischemia, and other conditions associated with insufficient blood flow to the heart. The test for cardiac biomarkers is used to determine an individual’s risk of having the above conditions.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX